Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
BNKL
|
Andre Jacques Auberton Herve
Director |
BUY
Open market or private purchase
|
Direct | 95,149 Added 50.0% |
-
|
Mar 26
2021 |
OSPN
|
T Kendall Hunt
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 263,400 Added 26.5% |
$6,603,438
$25.07 p/Share
|
Mar 26
2021 |
DFCO
|
Brian Bonar
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 9,700 Added 0.17% |
$3,298
$0.34 p/Share
|
Mar 26
2021 |
DSE
|
Css LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 425 Added 0.09% |
$3,060
$7.2 p/Share
|
Mar 26
2021 |
TELA
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect | 37,851 Added 2.34% |
$487,521
$12.88 p/Share
|
Mar 26
2021 |
TSI
|
Laird Landmann
PORTFOLIO MANAGER |
BUY
Open market or private purchase
|
Direct | 3,162 Added 0.48% |
$17,960
$5.68 p/Share
|
Mar 26
2021 |
NTRS
|
Becerra Jose Luis Prado
Director |
BUY
Open market or private purchase
|
Indirect | 2 Added 0.0% |
$209
$104.75 p/Share
|
Mar 26
2021 |
ICD
|
William Monroe
> 10% Shareholder |
BUY
Open market or private sale
|
Direct | 10,000 Added 1.4% |
$35,500
$3.55 p/Share
|
Mar 26
2021 |
BNKL
|
Remi Gaston Dreyfus
Director |
BUY
Open market or private purchase
|
Indirect | 135,560 Added 8.72% |
-
|
Mar 26
2021 |
DUSYF
|
Allen Wai Hong Chee
Director |
BUY
Open market or private purchase
|
Direct | 8,000 Added 0.76% |
$8,160
$1.02 p/Share
|
Mar 25
2021 |
PUBM
|
Cnh Capital CO LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 5,000 Added 0.78% |
$231,300
$46.26 p/Share
|
Mar 25
2021 |
MAXR
|
Daniel L Jablonsky
President and CEO |
BUY
Open market or private purchase
|
Direct | 1,500 Added 0.4% |
$53,580
$35.72 p/Share
|
Mar 25
2021 |
FTAI
|
Martin Tuchman |
BUY
Open market or private purchase
|
Indirect | 800,000 Added 50.0% |
$20,000,000
$25.0 p/Share
|
Mar 25
2021 |
SLP
|
Walter S Woltosz
Director |
BUY
Open market or private sale
|
Direct | 24,000 Added 0.53% |
$1,440,960
$60.04 p/Share
|
Mar 25
2021 |
ANIX
|
Arnold M Baskies
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 16.39% |
$48,000
$4.8 p/Share
|
Mar 25
2021 |
ANIX
|
Amit Kumar
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 5,000 Added 1.77% |
$24,300
$4.86 p/Share
|
Mar 25
2021 |
WINT
|
Steven Simonson
SVP, Chief Medical Officer |
BUY
Open market or private purchase
|
Direct | 1,500 Added 10.87% |
$4,875
$3.25 p/Share
|
Mar 25
2021 |
WINT
|
John P. Hamill
SVP & CFO |
BUY
Open market or private purchase
|
Direct | 1,500 Added 37.5% |
$4,875
$3.25 p/Share
|
Mar 25
2021 |
WINT
|
Craig Fraser
President and CEO |
BUY
Open market or private purchase
|
Direct | 1,500 Added 5.49% |
$4,875
$3.25 p/Share
|
Mar 25
2021 |
USPH
|
Harry S Chapman
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 2.86% |
$108,000
$108.0 p/Share
|
Mar 25
2021 |
GBDC
|
Lawrence E Golub
Chairman |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.1% |
$29,620
$14.81 p/Share
|
Mar 25
2021 |
GBDC
|
David Golub
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.1% |
$29,620
$14.81 p/Share
|
Mar 25
2021 |
DBI
|
Jay L Schottenstein
Executive Chairman |
BUY
Open market or private purchase
|
Indirect | 191,832 Added 23.36% |
$2,633,853
$13.73 p/Share
|
Mar 25
2021 |
WMPN
|
Kenneth John Stephon
President and CEO |
BUY
Open market or private purchase
|
Indirect | 4,356 Added 15.0% |
$49,005
$11.25 p/Share
|
Mar 25
2021 |
GNLN
|
Aaron Lo Cascio
Director |
BUY
Open market or private sale
|
Direct | 23,500 Added 31.03% |
$114,915
$4.89 p/Share
|
Mar 25
2021 |
LSAK
|
Monde Nkosi |
BUY
Open market or private purchase
|
Indirect | 35,425 Added 0.28% |
$193,775
$5.47 p/Share
|
Mar 25
2021 |
LSAK
|
Antony C Ball |
BUY
Open market or private purchase
|
Indirect | 35,425 Added 0.28% |
$193,775
$5.47 p/Share
|
Mar 25
2021 |
LSAK
|
Value Capital Partners (Pty) LTD |
BUY
Open market or private purchase
|
Indirect | 35,425 Added 0.28% |
$193,775
$5.47 p/Share
|
Mar 25
2021 |
BW
|
B. Riley Financial, Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 10,720,785 Added 33.13% |
$64,753,541
$6.04 p/Share
|
Mar 25
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 28 Added 0.22% |
$42,896
$1532.01 p/Share
|
Mar 25
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.25% |
$4,596
$1532.01 p/Share
|
Mar 25
2021 |
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.18% |
$1,721
$2.55 p/Share
|
Mar 25
2021 |
RBBN
|
Miguel A Lopez
EVP, CFO |
BUY
Open market or private purchase
|
Direct | 500 Added 2.17% |
$3,930
$7.86 p/Share
|
Mar 25
2021 |
LEU
|
Larry B Cutlip
SVP, FIELD OPERATIONS |
BUY
Open market or private sale
|
Direct | 7,500 Added 99.26% |
$178,500
$23.8 p/Share
|
Mar 25
2021 |
ANIX
|
Lewis H Titterton Jr
Director |
BUY
Open market or private purchase
|
Direct | 45,000 Added 4.94% |
$217,800
$4.84 p/Share
|
Mar 25
2021 |
ANIX
|
Emily Gottschalk
Director |
BUY
Open market or private purchase
|
Direct | 15,600 Added 50.0% |
$76,128
$4.88 p/Share
|
Mar 25
2021 |
MACK
|
Gary L Crocker |
BUY
Open market or private purchase
|
Indirect | 200 Added 0.69% |
$1,226
$6.13 p/Share
|
Mar 25
2021 |
NYC
|
Edward M Weil Jr.
Director |
BUY
Open market or private purchase
|
Direct | 150 Added 1.26% |
$1,307
$8.71 p/Share
|
Mar 25
2021 |
EDSA
|
Pardeep Nijhawan
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 3,000 Added 0.55% |
$15,750
$5.25 p/Share
|
Mar 25
2021 |
EDSA
|
Michael J Brooks
President |
BUY
Open market or private purchase
|
Direct | 3,500 Added 20.91% |
$18,165
$5.19 p/Share
|
Mar 25
2021 |
MDV
|
Jeffrey Randolph
Director |
BUY
Open market or private purchase
|
Direct | 46 Added 0.34% |
$1,059
$23.03 p/Share
|
Mar 25
2021 |
MDV
|
Aaron Scott Halfacre
CEO and President |
BUY
Open market or private purchase
|
Direct | 28 Added 0.34% |
$645
$23.03 p/Share
|
Mar 25
2021 |
MDV
|
Adam Scott Markman
Director |
BUY
Open market or private purchase
|
Direct | 20 Added 0.33% |
$461
$23.03 p/Share
|
Mar 25
2021 |
MDV
|
Curtis B Mc Williams
Director |
BUY
Open market or private purchase
|
Direct | 24 Added 0.34% |
$553
$23.03 p/Share
|
Mar 25
2021 |
MDV
|
Joe F Hanauer
Director |
BUY
Open market or private purchase
|
Direct | 11 Added 0.34% |
$253
$23.03 p/Share
|
Mar 25
2021 |
MDV
|
Thomas H Nolan Jr
Director |
BUY
Open market or private purchase
|
Direct | 22 Added 0.34% |
$507
$23.03 p/Share
|
Mar 25
2021 |
PFSI
|
Mfn Partners, LP
Director |
BUY
Open market or private purchase
|
Direct | 68,978 Added 5.09% |
$4,303,537
$62.39 p/Share
|
Mar 25
2021 |
FTCV
|
Daniel S Loeb
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 85,546 Added 2.77% |
$982,068
$11.48 p/Share
|
Mar 25
2021 |
PFSI
|
Farhad Nanji
Director |
BUY
Open market or private purchase
|
Indirect | 68,978 Added 5.09% |
$4,303,537
$62.39 p/Share
|
Mar 25
2021 |
VRE
|
A. Akiva Katz |
BUY
Open market or private purchase
|
Indirect | 345,963 Added 9.45% |
$5,369,346
$15.52 p/Share
|
Mar 25
2021 |